| News
BLKB expanding support for startups
12.01.2023
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies now have another opportunity to weigh up: From now on, they have the option of converting their loan into equity financing.

BLKB, the cantonal bank for the canton of Basel-Landschaft, is expanding its support program for innovative SMEs and startups. In future, BLKB will offer companies regarded as particularly promising from the “100 fürs Baselbiet” promotional program the opportunity to convert their loan into equity financing, further details of which can be found in a press release. BLKB cites a high degree of innovation, strong scalability and a successful due diligence check as prerequisites for this.
At the start of 2020, BLKB launched the “100 fürs Baselbiet” initiative in conjunction with the University of Applied Sciences and Arts Northwestern Switzerland (FHNW) and Economic Development Baselland. The aim of this project is to enable 100 companies with a link to the canton of Basel-Landschaft, colloquially referred to as the Baselland or Baselbiet, to take a decisive step forward in their further development.
Already 37 companies supported
BLKB board member Beat Röthlisberger is “very proud that after three years we can already support 37 innovative companies in their next development step”. As a result, these companies have been able to create 120 new jobs. Currently, the 37 companies are supported with a total amount of 13.7 million Swiss francs as well as extensive consulting services. In order to reinforce the positive effect, BLKB is now scaling up its commitment.
Together with the Baselland Chamber of Commerce and FHNW, the BLKB also organizes the Swiss Innovation Challenge. According to Arie Verkuil, who heads up the FHNW Institute of Management, a total of 850 applications with business concepts have been submitted in eight years. This shows that “the potential for further interested companies is definitely there”.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
Clinerion is now part of Citeline
Clinerion has been integrated into New York-based company Citeline. Clinerion plans to expand its portfolio with Citeline’s complementary opportunities with...
Read MoreKUORI developing biodegradable plastics
The Basel-based cleantech company KUORI GmbH develops alternative materials for conventional plastics. The aim is to reduce the accumulation of...
Read MoreCell and gene therapies gain momentum in Basel
Companies specializing in the research and development of innovative cell and gene therapies continue to spring up all around the...
Read MoreBLKB expanding support for startups
BLKB offers particularly promising SMEs and startups financial support within the framework of the “100 fürs Baselbiet” program. These companies...
Read MoreCombatting the rise of antimicrobial resistance
Antimicrobial resistance (AMR) is a growing global threat that, without intervention, could lead to as many as 10 million deaths...
Read MoreAMR Action Fund invests in new antibiotics developed by BioVersys
The AMR Action Fund has made its first European investment in BioVersys, which is headquartered at Tech Park Basel. The...
Read More